Global Cancer Immunotherapy Drug Discovery Outsourcing Market
Global Cancer Immunotherapy Drug Discovery Outsourcing Market was valued at USD 1.2 billion in 2021 and it is expected to reach USD 2.6 billion, at a CAGR 10.2% from 2022-2027.
Qualiket Research has recently published a new report, titled Global Cancer Immunotherapy Drug Discovery Outsourcing Market Insights, Forecast to 2022-2027. The report has been put together using primary & secondary research methodologies, which offer an accurate & precise understanding of the Cancer Immunotherapy Drug Discovery Outsourcing market. Analysts have used a top-down & bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Cancer Immunotherapy Drug Discovery Outsourcing market. The report offers an overview of the market, which briefly describes the market condition as well as the leading segments. It also mentions the key players present in the global Cancer Immunotherapy Drug Discovery Outsourcing market.
The research report on the global Cancer Immunotherapy Drug Discovery Outsourcing market includes a SWOT analysis and Porter's five forces analysis, which help in providing the precise trajectory of the Cancer Immunotherapy Drug Discovery Outsourcing market. These market measurement tools help in identifying drivers, restraints, challenges, Cancer Immunotherapy Drug Discovery Outsourcing market opportunities, and threats. The research report offers global market figures as well as figures for regional markets & segments therein.
The Cancer Immunotherapy Drug Discovery Outsourcing research report opens with an executive summary that gives a brief overview of the market. It mentions the leading segments & the players that are expected to shape the market in the coming years. The report also sheds light on the restraints present in the global Cancer Immunotherapy Drug Discovery Outsourcing market. Analysts have discussed the details highlighting the factors which are expected to hamper the growth of the market in the coming years.
Cancer Immunotherapy Drug Discovery Outsourcing Market Competitive Landscape
The last chapter of the research report on the global Cancer Immunotherapy Drug Discovery Outsourcing market focuses on the key players & the competitive landscape present in the market. The report includes a list of strategic initiatives taken by the companies in recent years along with the ones which are expected to happen in the foreseeable future. Researchers have made a note of the financial outlook of these companies, their research & development activities, and their expansion plans for the near future.
Cancer Immunotherapy Drug Discovery Outsourcing Market Leading Players
Covance, Inc.; Explicyte; Aquila BioMedical; Horizon Discovery Group PLC; Crown Bioscience, Inc.; Promega Corporation; HD Biosciences Co., Ltd.; BPS Bioscience, Inc.; Genscript Biotech Corporation; DiscoverX Corporation., etc.
Market Taxonomy
By Service Type
By Drug Type
By Cancer Type
By Region
Global Cancer Immunotherapy Drug Discovery Outsourcing Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Drug Type
5.1 Y-o-Y Growth Comparison, By Drug Type
5.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share Analysis, By Drug Type
5.3 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Drug Type
5.3.1 Monoclonal Antibodies
5.3.2 Immunomodulators
5.3.3 Oncolytic Viral Therapies and Cancer Vaccines
5.3.4 Others
6 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Service Type
6.1 Y-o-Y Growth Comparison, By Service Type
6.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share Analysis, By Service Type
6.3 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Service Type
6.3.1 Target Identification and Validation
6.3.2 Lead Screening and Characterization
6.3.3 Cell-based Assays
7 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cancer Type
7.1 Y-o-Y Growth Comparison, By Cancer Type
7.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share Analysis, By Cancer Type
7.3 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Cancer Type
7.3.1 Lung
7.3.2 Breast
7.3.3 Colorectal
7.3.4 Melanoma
7.3.5 Prostate
7.3.6 Head and Neck
7.3.7 Ovarian
7.3.8 Pancreatic
8 Global Cancer Immunotherapy Drug Discovery Outsourcing Market, By Region
8.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share Analysis, By Region
8.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share Analysis, By Region
8.3 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Region
9 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis and Forecast (2021-2027)
9.1 Introduction
9.2 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Share Analysis, By Drug Type
9.4 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Cancer Type
9.6 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Country
9.7.1 U.S.
9.7.2 Canada
9.7.3 Mexico
10 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis and Forecast (2021-2027)
10.1 Introduction
10.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Share Analysis, By Drug Type
10.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Service Type
10.4 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Cancer Type
10.6 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Country
10.6.1 Germany
10.6.2 France
10.6.3 UK
10.6.4. Rest of Europe
11 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis and Forecast (2021-2027)
11.1 Introduction
11.2 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Share Analysis, By Drug Type
11.3 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Service Type
11.4 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Cancer Type
11.6 Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Country
11.6.1 China
11.7.2 Japan
11.8.3 India
11.8.4. Rest of Asia Pacific
12 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis and Forecast (2021-2027)
12.1 Introduction
12.2 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Share Analysis, By Drug Type
12.3 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Service Type
12.4 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Cancer Type
12.6 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, Country
12.7.1. Brazil
12.8.2. Rest of Latin America
13 Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis and Forecast (2021-2027)
13.1 Introduction
13.2 Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market Share Analysis, By Drug Type
13.3 Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Service Type
13.4 Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Cancer Type
13.6 Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast, By Country
13.7.1. Saudi Arabia
13.8.2. UAE
13.8.3. Egypt
13.9.4. Kuwait
13.10.5. South Africa
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Covance, Inc
15.1.1 Overview
15.1.2 Drug Types
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. Explicyte
15.2.1 Overview
15.2.2 Drug Types
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. Aquila BioMedical
15.3.1 Overview
15.3.2 Drug Types
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Horizon Discovery Group PLC
15.4.1 Overview
15.4.2 Drug Types
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Crown Bioscience, Inc
15.5.1 Overview
15.5.2 Drug Types
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Promega Corporation
15.6.1 Overview
15.6.2 Drug Types
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 HD Biosciences Co., Ltd
15.7.1 Overview
15.7.2 Drug Types
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 BPS Bioscience, Inc
15.8.1 Overview
15.8.2 Drug Types
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Genscript Biotech Corporation
15.9.1 Overview
15.9.2 Drug Types
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 DiscoverX Corporation
15.10.1 Overview
15.10.2 Drug Types
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
